• Public Policy
  • Social Welfare
  • Urban Planning
  • Undergraduate Program
  • Stay in Touch
  • Events Calendar
  • Give Now
UCLA Luskin
  • About
    • Our Dean
    • Board of Advisors
    • Contact Us
    • Visit Us
    • Diversity, Disparities and Difference
    • Communications
      • UCLA Luskin in the News
      • Luskin Forum Online
    • Open Positions
  • Departments
    • Public Policy
    • Social Welfare
    • Undergraduate Program
    • Urban Planning
  • Apply
    • Master of Public Policy
    • Master of Social Welfare
    • Master of Urban and Regional Planning
      • Double Degree With Sciences Po
    • PhD in Social Welfare
    • PhD in Urban Planning
    • Undergraduate Programs
  • Faculty
    • Public Policy
    • Social Welfare
    • Urban Planning
  • Student Affairs & Alumni
    • Career Services
      • Employers
      • Fellowships
    • Student Support
    • Graduate Resource Library
    • Alumni Relations
  • Support
  • Programs
    • Research Centers & Affiliated Research
    • CalSWEC Public Child Welfare Program
    • Global Public Affairs (GPA)
    • Data Analytics Certificate
    • Luskin Lecture Series
    • Luskin Summit
    • Luskin Sacramento Briefing
    • Public Policy at 25
  • Administration
    • Graduate Resource Library
    • Academic Personnel
    • Financial Services
    • Emergency Safety
    • Events Office
      • Events Calendar
      • Reserve a Room
    • Human Resources
    • For New Staff and Faculty
    • Information Technology
  • Search
  • Menu Menu

Archive for: David Cohen

Study Finds Involuntary Psychiatric Detentions on the Rise Americans are increasingly being detained as a danger to themselves or others because of mental illness

November 3, 2020/0 Comments/in For Faculty, For Policymakers, For Students, Health Care, School of Public Affairs, Social Welfare, Social Welfare News David Cohen /by Les Dunseith

By Les Dunseith

The rate at which Americans are held against their will and forced to undergo mental health evaluations and even state-ordered confinement — lasting anywhere from a few days to years — has risen sharply over the past decade, according to a new study by researchers at the UCLA Luskin School of Public Affairs.

The analysis, published online today in the journal Psychiatric Services, shows that in the nearly half of U.S. states for which data was available, involuntary psychiatric detentions outpaced population growth by a rate of 3 to 1 on average in recent years.

The study is the most comprehensive compilation of data on involuntary detentions to date, the researchers say, an undertaking made more challenging by the lack of a national data set on the topic and longstanding inconsistencies in reporting across states and jurisdictions.

“This is the most controversial intervention in mental health — you’re deprived of liberty, can be traumatized and then stigmatized — yet no one could tell how often it happens in the United States,” said David Cohen, a professor of social welfare at the Luskin School, who led the research. “We saw the lack of data as a social justice issue, as an accountability issue.”

While each state has its own laws governing these detentions, nearly all specify that people who have not been accused of a crime but who may pose a danger to themselves or others or can’t take care of themselves — because of mental illness or substance abuse — can be detained in an authorized facility, usually a hospital, Cohen said. An initial evaluation can last several days, but detention can be extended at the discretion of mental health professionals.

Cohen and his co-lead author, Gi Lee, a social welfare doctoral student at the Luskin School, scoured health and court websites for all U.S. states and were able to cull usable counts on emergency and longer-term involuntary detentions from just 25 of them for the period from 2011 to 2018. In those 25 states, they found, annual detentions varied from a low of 29 per 100,000 people in Connecticut in 2015 to a high of 966 in Florida in 2018.

Twenty-two of those states had continuous data from 2012 to 2016, and the authors found that during this five-year span, the average yearly detention rate in these states increased by 13%, while their average population grew by just 4%, the authors say. Further, using data from 24 states that make up 52% of the country’s population, the researchers calculated a rate of 357 emergency involuntary detentions per 100,000 people in 2014 — a total of 591,000 detentions.

“If you think that coercion is necessary in mental health, then a rise in detention rates may be welcome news, a sign that society is doing whatever it takes to help people in crisis and keep order,” Cohen said. “But if you think that coercion is punishment, that we need services to prevent or defuse crises in families and society before they get out of control, then a rise is a bad sign.”

One of the most common triggers for a detention is a threat of suicide, said Cohen, who noted that the detentions often involve law enforcement personnel.

“The process can involve being strip-searched, restrained, secluded, having drugs forced on you, losing your credibility,” Cohen said. “For people already scarred by traumatic events, an involuntary detention can be another trauma.”

The rate of suicide is high for people recently released from psychiatric hospitalization, but how many of these hospitalizations are involuntary is not known, nor is it clear whether such detentions may play a protective or risk-increasing role in suicide. Likewise, while former involuntary detainees interviewed in previous studies have expressed both gratitude and resentment, data on the lasting effects of being coerced into a facility for psychiatric treatment is scarce, the authors say.

“These studies have mostly focused on subjective experiences of psychiatric detention, which are important to understand,” Lee said. “However, not much is known about more objective outcomes of psychiatric detention — on employment, education, contact with the criminal and juvenile justice systems, and others.”

Still, the authors stress that their study is not about whether involuntary psychiatric detention helps or hurts but about determining precisely how often it occurs in the U.S. in the hopes of spurring a national discussion on these issues. That, say Cohen and Lee, will come with more data.

Despite the current limitations, the researchers gleaned several other important findings from the available data:

  • Among the eight states that provided data on longer-term detentions, average annual rates over time ranged from lows of 25 (Oklahoma) and 27 (Missouri) per 100,000 people to highs of 158 (Virginia) and 159 (California). These longer-term detentions were, on average, 42.2% of the eight states’ rate of all emergency detentions.
  • 24 of the states studied comprised 52% of the U.S. population in 2014. Five of them — Florida, California, Massachusetts, Texas and Colorado — accounted for 59% of the population of those 24 states but were responsible for 80% of the total detentions that year.
  • While only six states provided information on the detention of minors, the researchers believe even this partial data is the most complete glimpse yet of the involuntary detention of minors in the U.S.

“Greater transparency in data would not only lead to a better understanding of the epidemiology of psychiatric detentions in the U.S.,” Lee said, “but could help determine to what extent commitment is a last resort.”

Eco-Anxiety and Other Labels Derail Social Activism, Cohen Says

September 17, 2020/0 Comments/in Luskin in the News David Cohen /by Zoe Day

Professor of Social Welfare David Cohen was featured in a Mad in America article discussing the mental health industry’s response to growing concerns about climate change. As the impacts of a warming planet have become more prominent, a new refrain has emerged that climate change causes mental health problems requiring treatment, including fear, sadness, eco-anxiety and PTSD. According to Cohen, the pathologizing and medicalizing of feelings about climate change derails social activism. He explained that the terms “mental health” and “mental illness” frame negative feelings in response to climate change as pathologies or illnesses inside individual brains that require psychiatric or psychological treatments rather than social-political solutions. Instead of encouraging social activism and environmental advocacy, this medicalization “enfeebles us, making us feel dependent on ‘expert’ health professionals to help manage these feelings,” Cohen said. He concluded that these medicalized diagnostic labels undermine the citizen empowerment necessary to effect change.

Read the article

Cohen on Relaxation of Liquor Laws During Coronavirus Outbreak

April 2, 2020/0 Comments/in Luskin in the News David Cohen /by Mary Braswell

Social Welfare Professor David Cohen spoke to the Hill about the temporary relaxation of laws on alcohol purchases during the coronavirus outbreak. Some states are now permitting takeout and delivery of alcoholic beverages to provide relief for restaurants and small businesses. Cohen said it was common to rethink regulations during emergencies but also cited the influence of the beer, wine and spirits lobby. “Regulations result from balancing many interests, but the weight of manufacturers, wholesalers and distributors of alcoholic beverages in influencing policy through lobbying is notable,” he said. Alcohol laws exist for a reason and relaxing them could be dangerous, he added. “Alcohol used excessively can lead to serious problems in people and in communities in the short and the longer term. If changes in access to alcohol occur, consequences must be monitored so we can understand more clearly the impact — desirable, undesirable and unanticipated — of our regulations,” he said.

Read the article

 

Cohen on the Perils of Overmedication

January 24, 2020/0 Comments/in Luskin's Latest Blog David Cohen /by Mary Braswell

“Medicating Normal,” a new documentary about the widespread use and resulting harms of anti-depressants, anti-anxiety medications, ADHD drugs and mood stabilizers, highlights research by Social Welfare Professor David Cohen, an authority on the benefits and risks of psychoactive drugs. The film notes that one in five Americans take these psychiatric medications daily but many are unaware of their potentially debilitating side effects. In the documentary and in online resources published by the filmmakers, Cohen weighs in on misconceptions about mental illness as brain damage; the challenges psychiatric patients face in providing fully informed consent; and the severe symptoms associated with withdrawal from benzodiazepines such as Xanax. He also spoke about the intense pressure on parents to medicalize their children’s problems, a break from previous generations. “You didn’t go to the doctor before if your kid misbehaved. You went to your sister-in-law or you went to your clergyman or you went to the Reader’s Digest,” Cohen said. “It’s hard right now in the contemporary world, in the 21st century, it’s hard for a parent to know, what should I do with my kid? … You get 20 different views on the internet, you are surrounded by opinions, and you’re supposed to do the right thing, the perfect thing.” Swayed by peer pressure, drug marketing and fear of making the wrong choice, many parents conclude that their children have a disorder and turn to medication, he said. “Medicating Normal,” which argues that profit-driven drug companies are concealing the harms caused by their products, was recently screened at the Santa Barbara International Film Festival.

Cohen on Weighing the Benefit of Antidepressants

September 10, 2019/0 Comments/in Luskin in the News David Cohen /by Mary Braswell

A Los Angeles Times column about the difficulty of coming off antidepressants quoted Social Welfare Professor David Cohen, whose research focuses on psychoactive drugs. The column noted that the number of Americans age 12 and over who use antidepressants has tripled over the last two decades. For some patients, ongoing treatment is the best option for a functional life. Others may opt to wean themselves from the drugs, which must be done with care to prevent severe withdrawal symptoms. “Users themselves must decide about meds’ helpfulness in their own lives,” said Cohen, who is associate dean for research and faculty development at UCLA Luskin. Two recent studies by Cohen looked at clinical trials funded by the pharmaceutical industry that appeared to misinterpret withdrawal symptoms as relapse, bolstering the case for staying on the medications and raising questions about the reliability of the trials.

Read the column

 

Cohen Offers Perspective on Mental Health Facilities

August 22, 2019/0 Comments/in Luskin in the News David Cohen /by Mary Braswell

Social Welfare Professor David Cohen provided context and history in a CNN report assessing the veracity of President Trump’s comments linking gun violence to the closure of mental health facilities. “They closed so many — like 92% — of the mental institutions around this country over the years, for budgetary reasons,” Trump said. Cohen clarified that, since the mid-1950s, about half of the nation’s psychiatric facilities have closed and the number of residents in state mental hospitals has fallen from about 550,000 to about 100,000 today. The facilities closed in an effort to “deinstitutionalize” the mentally ill by placing them in less restrictive environments — not because of budget cutbacks, he added. But many patients were left with nowhere to go. “Society after World War II discovered a new passion to solve social problems and include the excluded, and all sorts of institutions — including orphanages, institutions for mentally retarded persons, homes for unwed mothers, youth detention centers, etc. — were phased out, with their residents often in effect kicked out from where they had lived for years,” Cohen said.

Read the article

When Psychiatric Medications Are Abruptly Discontinued, Withdrawal Symptoms May be Mistaken for Relapse UCLA research contributes to assessing the reliability of industry-funded drug trials

April 19, 2019/0 Comments/in Education, For Faculty, For Policymakers, For Students, Health Care, Research Projects, School of Public Affairs, Social Welfare, Social Welfare News David Cohen /by Stan Paul

By Stan Paul

Withdrawal symptoms following the practice of discontinuation, or abruptly “coming off,” of psychiatric drugs in randomized clinical trials may be mistaken for relapse and bolster the case for continued use of medication, according to two new studies by UCLA researchers published in the journal Psychotherapy and Psychosomatics.

Principal investigator David Cohen, professor of social welfare in the UCLA Luskin School of Public Affairs, said that clinical trials employing a drug discontinuation procedure had not previously been studied systematically.

“For years, observers have asked whether people getting more symptoms when they came off their medication was their disorder returning or the withdrawal effects from drugs that could be reduced by more gradual, patient-centered discontinuation,” Cohen said.

In light of the difficulties that people have in discontinuing psychiatric medications, Cohen sought to answer that question, joined by co-author Alexander Récalt, a doctoral student in social welfare at UCLA Luskin who is also pursuing a master’s degree at the UCLA Fielding School of Public Health.

They looked at how and why antidepressants, antipsychotics and stimulants were deliberately discontinued from trial subjects in more than 80 randomized controlled trials from 2000–2017. The study also included benzodiazepines, a class of drugs such as Valium, upon which long-term users may become dependent and experience withdrawal symptoms.

In the first study, the researchers found:

  • In 67 percent of studies, no justification was given for a particular discontinuation strategy, which was abrupt or lasted less than two weeks in most cases (60 percent).
  • In 44 percent of studies that related to antidepressants, stimulants and antipsychotics, researchers used mainly abrupt discontinuation to test whether the drugs prevented relapse. Yet, researchers in most studies did not indicate that misclassifying a withdrawal reaction could occur.
  • Most studies incorporating benzodiazepines used discontinuation differently. These studies recognized that withdrawal symptoms were common, and they employed longer drug-tapering periods (more than eight weeks in most cases) to help people successfully come off and stay off these drugs.

The pharmaceutical industry was involved in 70 percent of the 80 studies; in most of the relapse-prevention studies; but in few of the benzodiazepines studies with longer tapering periods, according to the researchers.

Cohen, who also serves as associate dean for research and faculty development at UCLA Luskin, observed across the 80 studies that, in addition to testing relapse prevention, drug discontinuation was employed to chart withdrawal effects and to compare different methods of managing older and frail residents in institutions, given the known damaging effects of drugs taken over the long term.

But only a single study out of the 80 actually employed the discontinuation procedure in order to distinguish clearly between “relapse” and “withdrawal symptoms,” the researchers noted.

“This suggests to us that sponsors or researchers of discontinuation studies are really uninterested in exploring this crucial question,” Cohen said.

“Distinguishing between them requires careful history taking, an open mindset from the clinician and a degree of suspicion that the discontinuation process itself may be contributing.”

In many first-person accounts, patients have complained that they were not warned about these effects or told how slowly they should come off, Cohen said. Instead, their prescriber told them that the effects confirmed that the patients were better off taking the medication and therefore should continue to take it.

“The disconnect continues to drive a wedge between patients and their prescribers and is increasingly discussed in the media, as about one in six adult Americans take — increasingly for years — psychiatric drugs,” Cohen said.

“Our findings, if confirmed by other researchers looking at this literature, contribute to helping decide whether industry-funded drug trials in psychiatry are — as critics have maintained for years — infomercials for drugs or credible scientific investigations,” he said.

In their second study, Cohen and Récalt focused on whether they could detect evidence in the relapse-prevention randomized control trials that an actual misclassification — a confound — of relapse with withdrawal was occurring.

“Most publications do not raise the issue openly, so they do not provide the data to examine this issue directly,” said Cohen, explaining that an indirect method to test their hunch was used. Because withdrawal symptoms are known to begin to occur within an interval of time after drug discontinuation, the researchers focused on the timing of symptoms for drug-continued vs. drug-discontinued participants. They looked for evidence that end-of-study symptoms might already have been present during the study at set discontinuation times. A 50 percent rate of occurrence was chosen to indicate a substantial, non-trivial possible misclassification, Cohen said.

Few studies provided the data to actually test the hypothesis, even indirectly. Among the 14 studies that did provide the necessary data, about three-quarters showed evidence that withdrawal may be mistaken for relapse.

Relapse prevention trials that use psychiatric drug discontinuation commonly conclude that drugs work because they help prevent relapse, Cohen pointed out.

In line with a stream of previous warnings in the literature, the two studies show that more justifications are needed for why and how these discontinuation trials are conducted. Clinicians and consumers should not accept conventional interpretations of what is actually occurring to deliberately drug-discontinued participants in the trials, Cohen said, “and what this could mean for long-term use of psychiatric medications by ordinary people around the world.”

Cohen on Challenges of Tapering Off Antidepressants

April 9, 2019/0 Comments/in Luskin in the News David Cohen /by Zoe Day

Social Welfare Professor David Cohen’s comments on the side effects of coming off antidepressants were featured in a recent article in TheBody. A 60% increase in long-term antidepressant use between 2010 and 2018 has prompted research on “discontinuation syndrome,” or the intense side effects that make it difficult for patients to taper off. According to Cohen, “Coming off anything that alters how your brain functions, even coffee or tea, will provoke some kind of reaction. The brain is no longer getting that feedback from the drug, and it reacts to the removal.” After patients of one study rated their withdrawal experience, Cohen explained that “those who rated [their withdrawal] as most severe were coming off the fastest.” Experts recommend careful planning for coming off antidepressants, including a tapering plan, flexibility and a strong support system. “Go slow, and stay in your comfort zone. Feel it out as you go,” Cohen recommended.

Read the article

UCLA Luskin Faculty Among Top 100 Social Work Scholars

March 5, 2019/0 Comments/in Luskin's Latest Blog David Cohen, Robert Schilling, Yeheskel (Zeke) Hasenfeld /by Zoe Day

UCLA Luskin Professor David Cohen and Professors Emeritus Yeheskel “Zeke” Hasenfeld and Robert Schilling were recognized in the Journal of Social Service Research’s list of the “100 Most Influential Contemporary Social Work Faculty as Assessed by the H-Index.” The report uses a new method called the H-Index to measure the impact and influence of social work scholarship, taking into account not only the number of publications an individual has authored, but also the number of times that his or her work has been cited by others. “It feels great to be included in a list of highly cited scholars in my field — especially when some were my teachers,” said Cohen, who is also associate dean for research and faculty development at UCLA Luskin. “But creativity and quality mean more than citations — so I plan to keep on trucking, hoping that my best work is still ahead of me.” Cohen, whose research focuses on the effects of psychoactive drugs, treatment-induced harms and mental health trends, has authored and co-authored more than 100 book chapters and articles. Distinguished Research Professor Emeritus Hasenfeld, who passed away Feb. 28, 2019, was cited for his insightful investigation of the relationship between social welfare policies, the organizations that implement them and the people who use their services. Schilling’s research focuses on developmental disabilities, HIV risk and prevention, and substance abuse. Also on the list is Ron Avi Astor, who will join the UCLA Luskin faculty in the 2019-2020 school year. Astor is an internationally recognized expert on school safety. — Zoe Day

Read the report

20 Faculty and Students Present Research at Social Work Conference

January 18, 2019/0 Comments/in Luskin's Latest Blog Amy Ritterbusch, Ayako Miyashita Ochoa, Carlos Santos, David Cohen, Ian Holloway, Latoya Small, Laura Abrams, Laura Wray-Lake, Leyla Karimli /by Zoe Day

A contingent of 20 faculty and doctoral students from the UCLA Luskin School of Public Affairs are representing the School at the 2019 Society for Social Work and Research (SSWR) Conference  Jan. 16-20 in San Francisco. Research is presented during symposia, workshops, roundtable discussions, and paper and poster presentations at the annual conference, which in 2019 is dedicated to ending gender-based, family and community violence. “We’re excited to see so many of our faculty and Ph.D. students presenting,” said Laura Abrams, professor and chair of UCLA Luskin Social Welfare. The presentations cover a broad spectrum of topics within social work and research, including mental illness, gerontology, child welfare, adolescence and parenting, racial and ethnic minorities, and civic engagement. Featured UCLA Luskin Social Welfare faculty are Abrams, David Cohen, Ian Holloway, Aurora Jackson, Leyla Karimli, Ayako Miyashita Ochoa, Amy Ritterbusch, Latoya Small, Carlos Santos and Laura Wray-Lake. Presenting doctoral students from UCLA Luskin are Skye Allmang, Donte Boyd, Ryan Dougherty, Shannon Dunlap, Jianchao Lai, Gi Lee, Carol A. Leung, Jason Anthony Plummer, Alex Recault and Rachel Wells. Holloway, associate professor of social welfare, remarked, “We are very proud of our doctoral students presenting at SSWR this year. They are advancing social welfare scholarship and representing UCLA well at our premier social work research conference.”


 

Page 2 of 3123

Recent Posts

  • Torres-Gil on Ageism in Electoral Politics December 8, 2023
  • Astor Receives 2023 School Mental Health Research Award December 7, 2023
  • Michael Stoll Joins Board of Directors of American Institutes for Research December 6, 2023
  • Bringing Shade to Bus Stops Across L.A. December 5, 2023
  • A ‘Hesitantly Bullish’ Take on U.S. Unemployment Trends December 4, 2023

Contact

UCLA Luskin School of Public Affairs

3250 Public Affairs Building - Box 951656
Los Angeles, CA 90095-1656

Campus Resources

  • Maps, Directions, Parking
  • Directory
  • Contact
  • Academic Calendar
  • Careers
  • Diversity
  • University of California
  • Terms of Use

Follow

The statements on this page represent the views of people affiliated with the Luskin School of Public Affairs and do not necessarily represent the views of the University of California, or UCLA or its Chancellor.
  • About
    ▼
    • Our Dean
    • Board of Advisors
    • Contact Us
    • Visit Us
    • Diversity, Disparities and Difference
    • Communications
      ▼
      • UCLA Luskin in the News
      • Luskin Forum Online
    • Open Positions
  • Departments
    ▼
    • Public Policy
    • Social Welfare
    • Undergraduate Program
    • Urban Planning
  • Apply
    ▼
    • Master of Public Policy
    • Master of Social Welfare
    • Master of Urban and Regional Planning
      ▼
      • Double Degree With Sciences Po
    • PhD in Social Welfare
    • PhD in Urban Planning
    • Undergraduate Programs
  • Faculty
    ▼
    • Public Policy
    • Social Welfare
    • Urban Planning
  • Student Affairs & Alumni
    ▼
    • Career Services
      ▼
      • Employers
      • Fellowships
    • Student Support
    • Graduate Resource Library
    • Alumni Relations
  • Support
  • Programs
    ▼
    • Research Centers & Affiliated Research
    • CalSWEC Public Child Welfare Program
    • Global Public Affairs (GPA)
    • Data Analytics Certificate
    • Luskin Lecture Series
    • Luskin Summit
    • Luskin Sacramento Briefing
    • Public Policy at 25
  • Administration
    ▼
    • Graduate Resource Library
    • Academic Personnel
    • Financial Services
    • Emergency Safety
    • Events Office
      ▼
      • Events Calendar
      • Reserve a Room
    • Human Resources
    • For New Staff and Faculty
    • Information Technology
Scroll to top